A woman has sued two companies after she claims she developed tuberculosis after a bone graft procedure.
Andrea Collette filed her complaint in federal court against Elutia Inc., formerly known as Aziyo Biologics Inc., and Surgalign Spine Technologies Inc.
Accoding the complaint, Collette says she developed tuberculosis after a bone graft procedure involving ViBone, a human tissue allograft bone matrix produced by the defendants. The lawsuit claims the defendants' wrongful conduct in various stages of ViBone's production and distribution led to her personal injuries.
Collette underwent a LS5-S1 lumbar fusion with exploration of L4-L5 at East Jefferson General Hospital on May 30, 2023. The procedure involved the implantation of ViBone, which was developed, manufactured, marketed, promoted, distributed, supplied and/or sold by Elutia and/or Surgalign.
The court filing also mentions a previous urgent voluntary recall of FiberCel, another product manufactured by Elutia in 2021. The recall was issued after reports emerged of patients testing positive for Tuberculosis and post-surgical infections following surgical procedures involving FiberCel.
The plaintiff is seeking compensatory damages for her personal injuries caused by the alleged negligence of the defendants.